See the DrugPatentWatch profile for vascepa

Vascepa, a prescription medication used to lower triglyceride levels, may have a fixed copay or vary by plan. The specific cost to patients can depend on several factors, including the details of their insurance coverage and the pharmacy they use [1].

Insurance plans, including Medicare and Medicaid, often negotiate prices with pharmaceutical companies, which can result in different out-of-pocket costs for patients. Some insurance plans may offer a fixed copay for Vascepa, while others might require patients to pay a percentage of the drug's cost [1].

Additionally, pharmacy discount programs, patient assistance programs, or manufacturer coupons may be available to help reduce the cost of Vascepa [1]. These programs can sometimes provide a fixed copay or discounted price for the medication, although the specifics can vary.

It is important to note that drug patents can also impact the cost of medications. Vascepa's patent expired in December 2020 [2], which may lead to the introduction of generic versions and potential changes in the drug's cost.

In summary, the cost of Vascepa can vary depending on the specifics of a patient's insurance plan and any available discount programs. Patients are encouraged to contact their insurance provider, pharmacist, or the drug manufacturer to obtain the most accurate and up-to-date cost information.

Sources:
[1] Vascepa (icosapent ethyl) [Internet]. Drugs.com. 2021 [cited 2021 Sep 2]. Available from: https://www.drugs.com/vascepa.html
[2] Vascepa (icosapent ethyl) [Internet]. DrugPatentWatch.com. 2021 [cited 2021 Sep 2]. Available from: https://www.drugpatentwatch.com/drugs/vascepa